Dan Herendeen

Title: The Innovative Contributions of Dan Herendeen

Introduction

Dan Herendeen is a notable inventor based in Kirkland, WA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of PARP inhibitors. His work has implications for cancer treatment and showcases the importance of innovation in medical research.

Latest Patents

Dan Herendeen holds a patent for PARP inhibitors. The present invention provides compounds comprising a bicyclic aryl moiety, such as 2H-phthalazin-1-one or derivatives thereof, compositions comprising the same, and methods for producing and using the same. In particular, the present invention provides compounds of the formula: or a pharmaceutically acceptable salt, a hydrate, a solvate, or a prodrug thereof; where Q, Q, and Y are those defined herein. This patent highlights his expertise in creating novel compounds that can potentially enhance therapeutic options for patients.

Career Highlights

Throughout his career, Dan has worked with several prominent companies, including Icos Corporation and Deltagen Research Labs, LLC. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Dan has collaborated with notable professionals in his field, including Graham Beaton and Wilna J Moree. These partnerships have likely enriched his work and expanded the impact of his inventions.

Conclusion

Dan Herendeen's contributions to the field of pharmaceuticals through his patent on PARP inhibitors demonstrate his innovative spirit and commitment to advancing medical science. His work continues to inspire future research and development in the industry.